Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
RENOVION
company
About
RENOVION is a clinical stage pharmaceutical company that provides nebulized therapy.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $8.10M
- Industries
- Clinical Trials,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Renovion company is a pharmaceutical corporation with therapy for chronic inflammatory airway diseases. The company’s flagship pharmaceutical product, Arina-1, is still in pre-clinical stages.Renovation was formed in 2013 to leverage a pharmaceutical discovery at the University of North Carolina-Chapel Hill that reduces infection and addresses airway inflammation through the use of a novel therapy – Arina-1.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$8.10M
RENOVION has raised a total of
$8.10M
in funding over 2 rounds. Their latest funding was raised on
Jun 18, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 18, 2020 | Series A | $8.10M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
RENOVION is funded by 1 investors.
White Rock Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
